Innovative approaches to colorectal cancer prevention
https://doi.org/10.51523/2708-6011.2022-19-1-02
Abstract
The article discusses modern views on colorectal carcinogenesis and precancerous changes in the mucous membrane and presents the key summaries of the latest domestic, American, British, and European guidelines on healthcare enhancement for patients with premalignant colorectal lesions and their dynamic follow-up from the standpoint of cancer prevention.
About the Authors
S. A. Shut
Gomel State Medical University
Belarus
Belarus
Svetlana A. Shut, PhD (Med), Associate Professor, Associate Professor at Department of Internal Medicine No.2 with course of the Faculty of Professional Development and Retraining
Gomel
V. E. Platoshkin
Gomel Regional Clinical Oncological Dispensary
Belarus
Belarus
Viktar E. Platoshkin, radiation oncologist
Gomel
T. V. Platoshkina
Gomel Regional Clinical Oncological Dispensary
Belarus
Belarus
Tatyana V. Platoshkina, radiation oncologist
Gomel
N. A. Nikulina
Gomel State Medical University
Belarus
Belarus
Natalya A. Nikulina, PhD (Med), Associate Professor at Department of Internal Diseases No.2 with the course of the Faculty of Professional Development and Retraining
Gomel
N. V. Nikolaeva
Gomel State Medical University
Belarus
Belarus
Natalia V. Nikolaeva, PhD (Med), Associate Professor, Associate Professor at Department of Internal Medicine No.2 with the course of the Faculty of Professional Development and Retraining
Gomel
References
1. Healthcare in the Republic of Belarus: ofic. stat. sat. for 2018 [Electronic resource]. Minsk: GU RSPC MT; 2019. 261 p. [Date of access 2021 June 18]. Mode of access: http://rnpcmt.belcmt.by/files/Stat/Healthcare_in_RB_2018.pdf (in Russ.).
2. Cancer: world health organization Newsletter, 2018. [Electronic resource]. Global website of the world health organization. [Date of access 2021 June 18]. Mode of access: https://www.who.int/ru/news-room/fact-sheets/detail/cancer (in Russ.).
3. Oganov RG, Halfin RA, ed. Guide to medical prevention. [Electronic resource]. Moscow: GEOTAR-Media; 2007. 464 p. [Date of access 2021 June 18]. Mode of access: https://www.rosmedlib.ru/book/ISBN5970403385.html (in Russ.).
4. On the organization of cancer screening and early diagnosis: order of the Ministry of health of the Republic of Belarus, July 28, 2017, No. 830 national legal Internet portal of the Republic of Belarus [Electronic resource]. [Date of access 2021 June 18]. Mode of access: http://pravo.by/document/?guid=12551&p0=W21732115p&p1=1 (in Russ.).
5. Kit OI, Vodolazhskiy D., Gevorgyan SA, Soldatkina NV, Grechkin FN, Kozhushko MA. Hereditary colorectal cancer: genetics and screening. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018;28(3):18-25. Date of access 2021 June 18]. Mode of access: https:// www.gastro-j.ru/jour/article/view/236 (in Russ.). https://doi.org/10.22416/1382-4376-2018-28-3- 18-25
6. Storozhakov GI, Pozharitskaya EI, Fedorov IG. The problem of colorectal cancer screening Platoshkin EN, Mikhailova EI, Pimanov SI, Filipenko NV. Colorectal cancer screening. [Electronic resource]. Health and environmental issues. 2005;3(5):77-86. [Date of access 2021 June 18]. Mode of access: https://remedium.ru/doctor/oncology/detail.php?ID=64311
7. Mikhailova EI, Pimanov SI, Platoshkin EN, Filipenko NV. Screening for colorectal cancer (literature review). [Electronic resource]. Health and Ecology Issues. 2005;(3):77-86. Date of access 2021 June 18]. Mode of access: https://journal.gsmu.by/jour/article/view/358 (In Russ.).
8. Platoshkin EN, Borsuk AD. Possibilities of endoscopic diagnosis, treatment and monitoring of patients with precancerous pathology of the colon. [Electronic resource]. Collection of scientific articles of the International Scientific and Practical Conference “Chernobyl Readings -2009”; 2009 April 16-17; Gomel, Belarus. Gomel;2009:21-23. [Date of access 2021 June 18]. Mode of access: http:// rsek.nlb.by/cgi-bin/koha/opac-detail.pl?biblionum- ber=248171 (In Russ.).
9. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology. 2007 Jan;50(1):113-30. https://doi.org/10.1111/j.1365-2559.2006.02549.x
10. Grady WM, Carethers JM. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology. 2008;135:1079-1099. https://doi.org/10.1053/j.gastro.2008.07.076
11. Samowitz WS, Slattery ML, Sweeney C, et al. APC mutations and other genetic and epigenetic changes in colon cancer. Mol Cancer Res. 2007;5:165-170. https://doi.org/10.1158/1541-7786.MCR-06-0398
12. Nikishaev VI, Patiy AR, Tumak IN, Kolyada IA. Endoscopic diagnosis of early colorectal cancer. [Electronic resource]. Ukrainian journal of minimally invasive and endoscopic surgery. 2012;16(1):35-55. (In Russ.).
13. Tryakin AA, Fedyanin MYu, Tsukanov AS, Shelygin YuA, Pokataev IA, Ignatova EO, Khakimova GG, Frolova M, Tjulandin SA. Microsatellite instability as a unique characteristic of tumors and a predictor of response to immune therapy. Malignant tumours. 2019;9(4):59-69. (In Russ.) https://doi.org/10.18027/2224-5057-2019-9-4-59-69
14. Ageikina NV, Duvansky VA, Knyazev MV, Malkov PG, Danilova NV, Kharlova OA. An alternative way of development of colorectal cancer. Histological and molecular features of dentate lesions. Literature review. [Electronic resource]. Experimental and clinical gastroenterology. 2014;107(7):4-12. [Date of access 2021 June 18]. Mode of access: https://cyberleninka.ru/article/n/alternativnyy-put-razvitiya-kolorektalnogo-raka-gistogeneticheskie-i-molekulyarnye-osobennosti-zubchatyh-porazheniy (In Russ.).
15. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology. 2007;50:113-130. https://doi.org/10.1111/j.1365-2559.2006.02549.x
16. Advanced imaging for detection and differentiation of colorectal neoplasia: European Society of Gastrointestinal Endoscopy (ESGE) Guidline – Update 2019. Endoscopy. 2019;51(12):1155-1179. https://doi.org/10.1055/a-1031-7657
17. Singh H, Grewal N, Arora E, Kumar H, Kakkar AK. Vedolizumab: A novel anti-integrin drug for treatment of inflammatory bowel disease. J Nat Sci Biol. Med. 2016;7:4-9. https://doi.org/10.4103/0976-9668.175016
18. Feuerstein JD, Isaacs KL, Schneider Y et al. AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis. Gastroenterology. 2020;158:1450. https://doi.org/10.1053/j.gastro.2020.01.006
19. Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK. et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019:1-106. https://doi.org/10.1136/gutjnl-2019-318484
20. Adamina M, Bonovas S, Raine T, Spinelli A, Warusavitarne J, Armuzzi A, et al. European Crohn’s and Colitis Organisation [ECCO], ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment. Journal of Crohn’s and Colitis. 2020;14(2):155-168. https://doi.org/10.1093/ecco-jcc/jjz187
Review
For citations:
Shut S.A., Platoshkin V.E., Platoshkina T.V., Nikulina N.A., Nikolaeva N.V. Innovative approaches to colorectal cancer prevention. Health and Ecology Issues. 2022;19(1):13-20. (In Russ.) https://doi.org/10.51523/2708-6011.2022-19-1-02
Views: 384
Email this article 